HLA publishes full-length original articles, brief communications, commentaries and reviews covering all aspects of genetic control of immunity. The scope includes functional, biochemical, and genetic studies on molecules of the immune system, including cell surface receptors and their ligands, and encompassing cytokines, and chemokines, adhesion and co-stimulating molecules, antigen receptors such as TcR, NKR, CD1, PAMPs, Igs, KIR, and genes and products of the major histocompatibility complex including classical and non-classical HLA molecules. Papers should describe original research in vitro, or in animal models, or be clinical studies reflecting genetics of immunity in solid organ or haematopoietic stem cell transplantation, autoimmunity, infectious immunity, allergy, tumour immunity, vaccine science, pregnancy and disease susceptibility.
《Hla》是一本由WILEY出版商出版的專業醫學期刊,該刊創刊于2016年,刊期12 issues/year,該刊已被國際權威數據庫SCI、SCIE收錄。在中科院最新升級版分區表中,該刊分區信息為大類學科:醫學 4區,小類學科:病理學 3區;細胞生物學 4區;免疫學 4區;在JCR(Journal Citation Reports)分區等級為Q1。該刊發文范圍涵蓋細胞生物學等領域,旨在及時、準確、全面地報道國內外細胞生物學工作者在該領域取得的最新研究成果、工作進展及學術動態、技術革新等,促進學術交流,鼓勵學術創新。2021年影響因子為8.762,
大類學科 | 分區 | 小類學科 | 分區 | Top期刊 | 綜述期刊 |
醫學 | 4區 | CELL BIOLOGY 細胞生物學 IMMUNOLOGY 免疫學 PATHOLOGY 病理學 | 4區 4區 4區 | 否 | 否 |
JCR分區等級 | JCR所屬學科 | 分區 | 影響因子 |
Q1 | CELL BIOLOGY | Q1 | 8.762 |
IMMUNOLOGY | Q1 | ||
PATHOLOGY | Q1 |
影響因子 | h-index | Gold OA文章占比 | 研究類文章占比 | OA開放訪問 | 平均審稿速度 |
8.762 | 93 | 21.26% | 97.92% | 未開放 | -- |